Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis

Title
Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis
Authors
Keywords
Bleomycin, Pulmonary fibrosis, Inflammation, Epithelial-to-mesenchymal cell transition, Farnesoid X Receptor, Obeticholic acid
Journal
Publisher
Elsevier BV
Online
2017-01-21
DOI
10.1016/j.jsbmb.2017.01.010

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now